Rare occurrence of classical Hodgkin's disease as a T cell lymphoma by Muschen,  M. et al.
 387
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/01/387/08 $5.00
Volume 191, Number 2, January 17, 2000 387–394
http://www.jem.org
 
Brief Definitive Report
 
Rare Occurrence of Classical Hodgkin’s Disease as a
T Cell Lymphoma
 
By Markus Müschen,
 
*
 
‡
 
 Klaus Rajewsky,
 
*
 
 Andreas Bräuninger,
 
§
 
 
 
Audrey Sylvia Baur,
 
§
 
i
 
 Joost J. Oudejans,
 
¶
 
 Axel Roers,
 
*
 
Martin-Leo Hansmann,
 
§
 
 and Ralf Küppers
 
*
 
‡
 
From the 
 
*
 
Institute for Genetics, Department of Immunology, and the 
 
‡
 
Department of Internal 
Medicine, Universität zu Köln, 50931 Köln, Germany; the 
 
§
 
Department of Pathology, University of 
 
Frankfurt, 60596 Frankfurt, Germany; the 
 
i
 
University Institute of Pathology, University Hospital 
CHUV, 1011 Lausanne, Switzerland; and the 
 
¶
 
Department of Pathology, Free University Hospital, 
1081 HV Amsterdam, The Netherlands
 
Abstract
 
Recent work identified Hodgkin and Reed-Sternberg (H/RS) cells in classical Hodgkin’s disease
(cHD) as clonal progeny of mature B cells. Therefore, it is generally assumed that cHD homoge-
nously represents a B cell lymphoma. In a subset of cHD, however, H/RS cells expressing T
cell–associated proteins may be candidates for alternative lineage derivation. Single H/RS cells
with cytotoxic T cell phenotype were micromanipulated from three cases of cHD and analyzed
by single cell polymerase chain reaction for immunoglobulin heavy (IgH) and light chain (IgL)
gene rearrangements, T cell receptor (TCR)-
 
b
 
 gene rearrangements, and germline configura-
tion of the IgH and TCR-
 
b 
 
loci. H/RS cells from two cases of cHD harbored clonal, somati-
cally mutated Ig gene rearrangements, whereas TCR-
 
b 
 
loci were in germline configuration. In
contrast, H/RS cells from an additional case harbored clonal TCR-
 
b 
 
variable/diversity/joining
(VDJ) and DJ gene rearrangements, whereas the IgH locus was in germline configuration on
both alleles. Thus, in two cases of cHD with H/RS cells expressing cytotoxic T cell molecules,
the tumor cells are derived from mature B cells that aberrantly express T cell markers. In a third
case, however, H/RS cells were derived from a T cell, demonstrating that cHD can also occur
as a T cell lymphoma.
Key words: Hodgkin’s disease • T cell receptor genes • immunoglobulin genes • somatic 
hypermutation • Epstein-Barr virus
 
Introduction
 
In classical Hodgkin’s disease (cHD), the malignant Hodgkin
and Reed-Sternberg (H/RS) cells typically account for
 
,
 
1% of cells within a complex admixture of lymphocytes,
plasma cells, histiocytes, and eosinophils (1). The origin of
H/RS cells in cHD was enigmatic and a matter of debate
for more than a decade. Although H/RS cells usually lack
expression of B lineage markers, there is now strong evi-
dence that H/RS cells represent the outgrowth of a domi-
nant tumor clone derived from mature B cells (2, 3). This
 
conclusion is based on the amplification of clonally re-
lated Ig gene rearrangements from single micromanipulated
H/RS cells (4, 5). The presence and pattern of somatic
mutations in the rearranged V genes identified germinal
center B cells as the precursors of the tumor cells (5).
 
In a minority of cHD cases (
 
z
 
5–15%), however, H/RS
cells express cytotoxic T cell markers (granzyme B, perforin,
and T cell intracellular antigen 1 [TIA-1]), raising the possi-
bility that the tumor cells in these cases might originate from
T lymphocytes (6–9). To clarify whether H/RS cells in
such cases are indeed derived from T lymphocytes, H/RS
cells were micromanipulated and subjected to single cell PCR
analysis for rearranged Ig heavy chain (IgH), Ig
 
k
 
, and Ig
 
l
 
light chain genes, TCR-
 
b 
 
VDJ and DJ gene rearrangements,
as well as IgH and TCR-
 
b
 
 germline configuration (i.e., ab-
sence of rearrangements). Whereas IgH VDJ gene rearrange-
ments are specific for and restricted to B lineage cells, the
presence of TCR-
 
b
 
 VDJ gene rearrangements identifies a
T cell. Studying H/RS cells from three such cases, a B cell
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genotype was found in two, a genotype revealing T cell or-
igin in one case.
 
Materials and Methods
 
Clinical data on the three cases of cHD are summarized in Ta-
ble I.
 
Immunostaining and Micromanipulation.
 
For immunostaining,
6–7-
 
m
 
m frozen tissue sections were stained using antibodies against
CD30 (Fig. 1 A), CD20, LMP1, anaplastic lymphoma kinase
(ALK)-1 (Dako), CD15 (Fig. 1 C; Becton Dickinson), CD3
(Ortho), TCR-
 
a
 
/
 
b
 
 (T Cell Diagnostics), perforin (Neo Markers),
granzyme B (Monosan), and TIA-1 (Immunotech). Stained cells
were mobilized and aspirated with the help of a micropipette fixed
to a hydraulic micromanipulator. Multiple cells were picked from
each section. Buffer covering the sections was aspirated as negative
controls for PCR analysis. For positive control of PCR, single B and
T cells were either micromanipulated or sorted by flow cytometry.
 
Single Cell PCR.
 
To analyze individual micromanipulated
cells for IgH, Ig
 
k
 
, Ig
 
l
 
, as well as TCR-
 
b
 
 VDJ and DJ gene rear-
rangements or germline configuration of the IgH and TCR-
 
b
 
loci, whole genome preamplification (10) was performed. Aliquots
from these reactions were then subjected to two rounds of semi-
nested PCR amplification as described previously. For analysis of
the IgH and TCR-
 
b
 
 loci, three PCR strategies were applied
(Fig. 2, A and B), one of which targets IgH (Fig. 2 A, iii) or
TCR-
 
b
 
 (Fig. 2 B, iii) VDJ rearrangements, a second IgH (Fig. 2
A, ii) or TCR-
 
b
 
 (Fig. 2 B, ii) DJ rearrangements, and a third de-
tects germline configuration of either the IgH (Fig. 2 A, i) or the
TCR-
 
b
 
 (Fig. 2 B, i) locus. Rearranged V
 
H
 
, V
 
k
 
, and V
 
l 
 
genes
were amplified using family-specific leader or framework region
V gene primers and two sets of J
 
H
 
, J
 
k
 
, and J
 
l
 
 primers in a semi-
nested approach (5, 11, 12). D
 
H
 
J
 
H
 
 rearrangements and germline
configuration within the IgH locus were detected using seven D
 
H
 
family–specific primers and two sets of J
 
H
 
 gene–specific primers
 
in a seminested approach (5). In the case of germline configura-
tion of the IgH locus, a 340-bp fragment was obtained with the
D
 
H
 
7 primer, due to the close vicinity of the D
 
H
 
7-27 gene seg-
ment and J
 
H
 
1 (Fig. 2 A, i). D
 
H
 
 family–specific primers were as fol-
lows: 5
 
9
 
-GTGTGCAGGCCTCRGTCTCTGTG-3
 
9
 
 for the D
 
H
 
1
gene family; 5
 
9
 
-GCACTGGGCTCAGAGTCCTCTC-3
 
9
 
 for the
D
 
H
 
2 family; 5
 
9
 
-CCTCAGGTCAGCCCTGGACATC-3
 
9
 
 for the
D
 
H
 
3 family; 5
 
9
 
-TGAGATCCCCAGGACGCAGCAC-3
 
9
 
 for
the D
 
H
 
4 family; 5
 
9
 
-TCCCTGGGAAGCTCCTCCTGAC-3
 
9
 
 for
the D
 
H
 
5 family; 5
 
9
 
-GACACCAGACAGAGGGGCAGGC-3
 
9
 
for the D
 
H
 
6 family; and 5
 
9
 
-AGAGTGACTGGCAGGGTTG-
AGG-3
 
9
 
 for the D
 
H
 
7–27 gene. Amplification of TCR-
 
b
 
 VDJ
gene rearrangements was carried out as described previously using
a panel of 24 V
 
b
 
 family–specific primers and two sets of J
 
b
 
 gene–
specific primers in a seminested approach (13). Germline config-
uration was detected separately for both C
 
b
 
 loci (Fig. 2 B, i)
using primers binding to intronic sequences flanking the D
 
b
 
1
(5
 
9
 
-CCCCTTCGCCAAACAGCCTTA-3
 
9
 
 as forward, 5
 
9
 
-GAG-
TGAGGCAGAGGCATTCTGAAC-3
 
9
 
 as external reverse, and
5
 
9
 
-GCAGAGGCATTCTGAACCAAATTG-3
 
9
 
 as internal reverse
primer) or the D
 
b
 
2 gene (5
 
9
 
-TCAGGGTGATGCATGTTC-
CAAGGA-3
 
9
 
 as forward, 5
 
9
 
-GGGACCCTGCAAGACCACA-
GCT-3
 
9
 
 as external reverse, and 5
 
9
 
-ACTCTTCCCACCTGGTA-
GCTGCAT-3
 
9
 
 as internal reverse primer). D
 
b
 
J
 
b
 
 rearrangements
were amplified using the primers specific for intronic sequences
in the upstream regions of the D
 
b
 
1 and the D
 
b
 
2 genes, together
with primers specific for the J
 
b
 
1 or J
 
b
 
2 gene clusters, respectively
(Fig. 2 B, ii).
EBV infection of single H/RS cells was examined by amplifi-
cation of a fragment of the EBV nuclear antigen 1 (EBNA1) gene by
seminested PCR (5
 
9
 
-GGTCGCCGGTGTGTTCGTATATGG-3
 
9
 
as forward, 5
 
9
 
-GCGGCAGCCCCTTCCACCATAG-3
 
9
 
 as exter-
nal reverse, and 5
 
9
 
-AGGGAGGCAAATCTACTCCATCGTC-3
 
9
 
as internal reverse primer).
PCR products were gel-purified and directly sequenced.
Figure 1. Immunostaining of cHD, case
III. Histological stainings were as follows:
(A) the tissue is stained for CD30 with the
use of alkaline phosphatase (4-fold magnifi-
cation); (B) hemalaun-eosin staining of
some multinucleated Reed-Sternberg cells
at 60-fold magnification; (C) staining for
CD15 at 40-fold magnification. Staining of
this case for expression of perforin is shown
on the cover illustration of this issue.
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Results
 
H/RS cells from all three cases studied exhibit the typi-
cal immunophenotype of the tumor cells in cHD, as they
coexpress CD30 and CD15 (for case III, see Fig. 1) but lack
expression of the B cell antigen CD20 (Table I). H/RS cells
from cases I and II express in part granzyme B (see cover of
this issue), and TIA-1 and are EBV-positive, whereas H/RS
cells from case III express perforin in addition to granzyme
B and TIA-1 and are EBV-negative (Table I). Since the
majority of anaplastic large cell lymphomas express one or
more of the cytotoxic T cell markers studied here (7–9), di-
agnosis of cHD was further corroborated by the lack of nu-
 
cleophosmin(NPM)-ALK gene expression in the H/RS
cells. The NPM-ALK fusion protein arises from the translo-
cation t(2; 5) (p23; q35), which is typically seen in anaplastic
large cell lymphoma but not in cHD (14).
Efficiency of PCR amplification from single micromanip-
ulated cells for all three cases was similar to that usually en-
countered (i.e., 
 
,
 
40%, likely due to technical matters such
as partial degradation or inaccessibility of DNA [3–5, 11–
13]; Table II).
From case I, 50 CD30
 
1
 
 and 15 granzyme B
 
1
 
 H/RS cells
were micromanipulated and analyzed by single cell PCR.
Figure 2. Amplification of
IgH gene and TCR-b gene rear-
rangements from H/RS cells.
PCR strategies for amplification
of PCR products which are spe-
cific for IgH (A) or TCR-b (B)
germline configuration (i), DJ
gene rearrangements (ii), and
VDJ gene rearrangements (iii)
are depicted. VH1-VH7 and Vb1-
Vb24 represent the seven Ig VH
gene families and the 24 TCR
Vb gene families; and JH1-JH6
and Jb1.1-1.6 and Jb2.1-2.7 in-
dicate the Ig JH and the TCR Jb
genes, respectively. The IgH DJ
(A, ii) and IgH VDJ (A, iii) rear-
rangements and TCR-b DJ (B,
ii) and TCR-b VDJ (B, iii) rear-
rangements depict those ampli-
fied from cases I and III, respec-
tively. Arrows indicate the PCR
primers used (not to scale). (C) A
fragment (codons 95–115) of the
sequence alignment of the clonal
TCR Vb7.1–Db1–Jb1.6 rear-
rangement amplified from single
H/RS cells of case III is given.
The germline sequence of Vb7.1,
Db1, and Jb1.6 genes (top) is
compared with the clonal se-
quence variants (A, B, and C)
obtained from eight, two, and
four H/RS cells of case III, re-
spectively. The three sequence
variants (A, B, and C) differ by
single nucleotide substitutions in
codons 98, 105, and 108 (com-
plete sequence data are available
from GenBank/EMBL/DDBJ
under accession nos. AJ243645–
AJ243647). (D) Sequence align-
ment of the clonal TCR Db1–
Jb1.4 rearrangement amplified
from 14 H/RS cells of case III is
given. In contrast to the clonal
Vb7.1 gene rearrangement (C),
the Db1–Jb1.4 gene rearrange-
ment does not exhibit intraclonal
diversity (complete sequence
data is available from GenBank/
EMBL/DDBJ under accession
no. AJ243648).
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From multiple H/RS cells of both subsets, a clonal Ig VH2-
5–DH3-10–JH5b and a clonal DH3-9–JH6c gene rearrange-
ment were amplified. The VH2 gene was rearranged in-
frame, all sequences were identical, and the rearrangement
was rendered nonfunctional by a somatic mutation gener-
ating a translation stop in codon 91 of framework region III
(Table III). Thus, case I represents another example in which
the H/RS cells have lost their capacity to express antigen
receptor due to deleterious somatic mutations (5). No IgL,
TCR-b VDJ, or DJ gene rearrangements were obtained
analyzing multiple cells (Table II). Fragments correspond-
ing to germline configuration of the IgH locus were not
obtained, but fragments specific for germline configuration
of the TCR Cb1 and Cb2 loci were repeatedly amplified
(Table II). For the TCR Cb2 locus, germline configura-
tion could be assigned to both alleles because of the detec-
tion of two polymorphic forms of the Db2 gene (G and/or
A at position 13 of the Db2 gene; see reference 15).
Case II, which we studied previously for Ig gene rearrange-
ments (4), was retrospectively found to express granzyme B
and TIA-1 in a fraction of H/RS cells (Table I). 20 CD301
H/RS cells and 10 TIA-11 H/RS cells were micromanip-
ulated and analyzed for IgH and Igk gene rearrangements
and configuration of the TCR-b loci. Two clonal IgH and
one clonal Igk gene rearrangement were amplified from
H/RS cells regardless of their phenotype (Tables II and III).
VH and Vk genes were somatically mutated. The Vk region
gene and one of the VH gene rearrangements, which had both
likely been originally productive, were rendered nonfunc-
tional by somatic mutations (Table III). For unknown reasons,
a second clonal Vk gene rearrangement amplified in the first
analysis was not obtained in the present study. No TCR-b
gene rearrangements, but instead germline configuration for
the TCR Cb1 and Cb2 loci, were detected (Table II).
Taking cases I and II together, amplification of clonal VH
gene rearrangements rendered non-functional by deleteri-
ous somatic mutations together with the detection of germ-
line configuration in both TCR-b loci identify the H/RS
cells in these cases as the progeny of germinal center B cells
that have lost their capacity to express antigen receptor due
to “crippling” somatic mutations.
From case III, in which virtually all H/RS cell express
perforin (Table I), 30 CD301 H/RS cells were analyzed for
IgH, Igk, and Igl gene rearrangements (half of the cells
were in addition analyzed with VH leader, IgH DJ, and IgH
germline primer collections). Only one IgH VDJ gene am-
plificate was obtained, likely representing cellular or other
contamination (Table II). No IgH DJ gene rearrangement
was obtained. However, a fragment specific for germline con-
figuration was repeatedly amplified from H/RS cells. Within
these IgH germline fragments, two distinct sequences of
the JHc1 pseudogene (G and/or A at position 45 of the JHc1
pseudogene; see reference 16) were detected, suggesting
that both alleles of the IgH locus are in germline configura-
tion. In contrast, analysis of the TCR-b loci yielded two
clonal rearrangements involving the two alleles of the TCR
Cb1 locus in about half of the H/RS cells. One allele har-
bors a clonal Vb7.1–Db1–Jb1.6 rearrangement (Fig. 2 C),
whereas the other carries a clonal Db1–Jb1.4 gene rear-
rangement (Fig. 2 D). The Vb7.1 gene rearrangement is
potentially functional. Unexpectedly, it exhibits intraclonal
diversity (Fig. 2 C). Three different sequences were obtained
(Fig. 2 C, sequences A–C). The three sequence variants
were confirmed by repeated reamplification and sequencing
from distinct aliquots of the whole genome amplification.
Taken together, in case III the single cell PCR results iden-
tify a T cell as the progenitor of the tumor clone, thus clas-
sifying this case of cHD as a T cell lymphoma.
Discussion
Derivation of H/RS cells from mature B cells was previ-
ously demonstrated in 18 out of 18 informative unselected
cases of cHD analyzed in Cologne and Frankfurt (3–5, 17–
19). In addition, recent results obtained by others indicate
B cell derivation of H/RS cells in 24 out of 25 cases of cHD
(20). On the other hand, in a nonselected collection of 13
cases of primary cHD, Daus and colleagues did not detect
clonal TCR-g gene rearrangements in micromanipulated
H/RS cells from any of these cases (21). Therefore, these
data collectively indicate that cHD represents a homoge-
nous entity as a B cell lymphoma.
Table I. Case Description of Patients with cHD
Case I II III
Age 31 26 51
Sex Male Male Male
Presentation First First First
LN biopsy site Abdominal Cervical Inguinal
Stage IIB I II
Hodgkin
subtype Mixed cellularity Mixed cellularity Nodular sclerosis
Phenotype of 
H/RS cells
CD30 1 1 1
CD15 1 1 1
CD20 2 2 2
CD3 2 2 2
TCR-a/b 2 ND 2
Granzyme B 1 (90%) 1 (60%) 1 (40%)
Perforin 2 2 1 (100%)
TIA-1 1 (60%) 1 (.90%) 1 (40%)
EBV 1 1 2
ALK 2 ND 2
Numbers in parentheses indicate percentages of positive Reed-Sternberg
cells. Presence or absence of EBV was determined by amplification of a
fragment of the EBNA1 gene from single H/RS cells, and the results
were further confirmed in case I by LMP1 staining and in case III by
EBER in situ hybridization. ALK expression is indicative for the t(2;5)
translocation resulting in the expression of a fusion molecule with NPM.
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Table II. Summary of Single Cell PCR Analysis of Three Cases of cHD
Case Gene locus*
Staining for
micromanipulation
H/RS cells
positive
PCR products
Rearrangements or
germline configuration
Buffer controls
positiveTotal Sequenced Repeated Unique‡
I IgH CD30 21/50 19 VH2 17 17 VH2 0/15
1 VH3 1 1 VH3
1 VH4 1 1 VH4
9/14 9 DH3–JH 9 9 DH3-9–JH6c 0/4
Granzyme B 3/15 3 VH2 3 3 VH2
Igk CD30 0/16 0/4
Igl CD30 0/8 0/4
TCR Cb1 CD30 9/20 9 germline 9 9 germline 0/14
Granzyme B 3/15 3 germline 3 3 germline
TCR Cb2 CD30 9/20 9 germline 9 9 germline§ 0/14
Granzyme B 3/15 3 germline 2 2 germline
EBNA1 CD30 7/10 7 EBNA1 0/4
II IgH CD30 8/20 6 VH1 6 6 VH1 0/6
7 VH3 6 6 VH3
TIA-1 3/10 2 VH1 2 2 VH1 0/6
3 VH3 2 2 VH3
Igk CD30 9/20 9 Vk1 7 7 Vk1 0/6
TIA-1 2/10 3 Vk1 2 2 Vk1
TCR Cb1 CD30 4/20 4 germline 0/4
TIA-1 6/10 6 germline
TCR Cb2 CD30 9/20 9 germline 0/4
TIA-1 4/10 4 germline
EBNA1 CD30 8/20 8 EBNA1 0/6
TIA-1 5/10 5 EBNA1
III IgH CD30 1/30i 1 VH3 1 1 VH3 0/10
6/15 6 germline 6 6 germline§ 0/4
Igk CD30 0/30 0/10
Igl CD30 0/30 0/10
TCR Cb1 CD30 20/30 14 Vb7 14 14 Vb7 1/10¶
14 Db1–Jb1 14 14 Db1–Jb1.4
1 germline 1 1 germline
TCR Cb2 CD30 17/30 17 germline 7 7 germline 0/10
EBNA1 CD30 0/10 0/4
Controls: Micromanipulated Sorted by flow cytometry
Gene locus B cells T cells B cells T cells
IgH VDJ 5/22 0/12 8/15
DJ/germline 9/10
Igk 3/14 4/7
Igl 3/14 3/7
TCR-b VDJ 6/22 7/9
DJ/germline 16/22 16/18
*For IgH and IgL loci, only V(D)J rearrangements; for TCR-b loci, VDJ and DJ rearrangements as well as fragments specific for germline configurations 
were amplified. Cases I and III were also analyzed for DHJH rearrangements and germline configuration of the IgH locus.
‡Representing most likely cellular or other contamination.
§These loci were found in germline configuration on both alleles due to a germline polymorphism of the Db2 gene (case I) and the JHc1 gene (case III).
i15 of the H/RS cells from case III were in addition analyzed using VH leader primers.
¶The contamination amplifed from one buffer control represents a TCR Cb1 germline PCR product.
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However, there are some observations raising the possi-
bility that—in a subset of cHD—the tumor cells might
stem from T lymphocytes. Some putative H/RS cell lines,
for example, are derived from T cells (2). For these cell
lines, proof of derivation from H/RS cells in the patients is
missing. Furthermore, a TCR-a gene rearrangement was
amplified from whole tissue DNA of lymphomatoid papu-
losis, cHD, and anaplastic large cell lymphoma occurring
sequentially in one individual patient, suggesting a com-
mon T cell derivation of the three diseases (22). However,
assignment of T cell genotype to H/RS cells of the Hodgkin’s
lymphoma was not conclusive: anaplastic large cell lym-
phoma versus classic cHD is often a difficult differential di-
agnosis (1, 14). In this case, a clear discrimination between
the two entities was particularly complicated because H/RS
cells coexpressing CD30 and CD15 were found in both
lymphomas. Furthermore, the TCR-a gene rearrangement
identified in the Hodgkin’s disease biopsy with the help of
clone-specific primers represented a faint band, which
might have arisen from a few contaminating cells originat-
ing from either the lymphomatoid papulosis or the anaplas-
tic large cell lymphoma instead of the cHD. Finally, H/RS
cells in a minority of cHD cases express cytotoxic granular
molecules, in particular granzyme B, perforin, and TIA-1,
which are otherwise typically found in cytotoxic T lym-
phocytes (6–9). Three such cases were analyzed here.
In cases I and II, molecular analysis of Ig and TCR-b loci
revealed that the H/RS cells, despite expression of granzyme
B and TIA-1 (Table I), were derived from germinal center B
cells. Thus, expression of granzyme B and TIA-1 does not
necessarily reflect a T cell origin of H/RS cells and shows
that granzyme B and TIA-1 are aberrantly expressed by B
lineage–derived H/RS cells. Similarly, expression of mole-
cules thought to be specific for cells of the dendritic/myeloid
lineage (23) by H/RS cells does not apparently reflect a der-
ivation of these cells from dendritic or myeloid cells. Thus,
H/RS cells can mimic cells of various hematopoietic lineages
in terms of cell surface marker expression.
In case III, the H/RS cells harbor a clonal TCR-b VDJ
and a clonal DJ gene rearrangement but no clonal Ig gene
rearrangement. Furthermore, the IgH locus was found in
germline configuration biallelically, directly demonstrating
the absence of clonal IgH gene rearrangements. Given that
the presence of a TCR-b VDJ gene rearrangement defines
a T cell, the H/RS cells in this case are derived from a T
lymphocyte. The Vb7.1 gene rearrangement amplified from
the T cell tumor clone exhibits significant intraclonal diver-
sity. This was not expected, since TCR genes in T cells are
usually not subject to somatic hypermutation, although
there are some reports claiming the rare occurrence of so-
matically mutated TCR genes (24–26). Notably, somatic
mutations were not observed in the Db1–Jb1.4 rearrange-
ment or in intronic sequences flanking the germline Db2
gene (830-bp sequences; see Table II). The distribution of
somatic mutations among the distinct gene fragments of the
TCR-b loci argues in favor of somatic hypermutation rather
than some other type of somatic mutation (e.g., “genomic
instability”) as the cause for the mutations in the TCR-b
VDJ genes: in analogy to the Ig loci, somatic hypermuta-
tion would be expected to preferentially target VDJ joints
rather than DJ rearrangements or germline genes, whereas
genomic instability should not specifically target rearranged
VDJ genes. Whether these mutations indeed reflect somatic
hypermutation outside Ig loci, however, remains unclear.
In z5–15% of all cases of cHD, the H/RS cells exhibit cy-
totoxic T cell phenotype. Studying three of these cases, we
Table III. Sequence Analysis of Clonal Ig and TCR-b Gene Rearrangements
Case Gene locus Rearrangement*
Potentially
functional
Percent
mutation Remarks
I IgH VH2-5–DH3-10–JH5b No‡ 4.3 Stop (codon 91)
DH3-9–JH6c n.a. 0.9
TCR-b loci in germline
II IgH VH1-8–DH3-22–JH6b§ Noi 3.5 47-bp deletion;
IgH VH3-53–DH2-2–JH6b§ No¶ 1.9 Stop in CDR3
Igk§ Vk1 (L12)–Jk1§ No‡ 1.3 Stop in CDR3
TCR-b loci in germline
III TCR-b Vb7.1–Db1–Jb1.6 Yes 0.3–0.7 Sequence variations involving codons 
98, 105, and 108; three variants
TCR-b Db1–Jb1.4 n.a. 0
IgH locus in germline
n.a., not applicable.
*Sequences of cases I and III are available from GenBank/EMBL/DDBJ under accession nos. AJ243643–AJ243648 and AJ251000–AJ251002.
‡These rearrangements were potentially functional before introduction of a stop codon.
§Sequences of this case have been published previously (reference 4).
iThis rearrangement was potentially functional before the 47-bp deletion.
¶This rearrangement was likely originally nonfunctional due to a stop codon generated during VDJ recombination.
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found one to be T cell derived. Apart from this, 18 out of 18
nonselected cases of cHD in our collection are B lineage de-
rived. On this basis, a rough estimate would be that cHD oc-
curs as a T cell lymphoma at a low frequency (i.e., ,5%).
This study establishes that rare cases of cHD derived
from T cells indeed exist, indicating that cHD as defined by
histopathology is not a uniform disease. It is remarkable
that the transformation of both T and B cells can lead to the
H/RS cell phenotype. Whether this reflects an initial trans-
forming event inside the germinal center microenviron-
ment in both cases and whether T and B cell derived H/RS
cells can be distinguished in terms of gene expression pat-
terns remain to be established.
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